BTG gets its blood up over launch

A NEW treatment for varicose veins should be launched in Europe in 2005, says British technology group BTG. The pain-free alternative to surgery could generate annual revenues of £500m, say analysts.

BTG, which buys rights to new technologies, reports trebled losses of £22m for last year. The shares fell 16p to 359p.